Stocks Health care LGVN
NASDAQ · Health careLongeveron Inc. (LGVN)
Longeveron Inc. brought in $1.2M of revenue over the twelve months to June 30, 2026, down 42.7% from a year earlier. It posted a net loss of $23.5M. In fiscal 2025 capital spending exceeded operating cash flow by $18.9M. At June 30, 2026 it held $10.1M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 12, 2026.
Key facts about Longeveron Inc.
- Net worth
- Longeveron Inc. has a market value (market cap) of $101.4M at the latest share price, and shareholders' equity of $10.4M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $1.2M (-49.9% year on year), with a net loss of $22.7M. Over the 12 months to June 30, 2026: revenue $1.2M, net loss $23.5M.
- Cash flow
- In fiscal 2025 operations used $18.6M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 12, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
- Next earnings report
- Longeveron Inc.'s next report was expected around November 3, 2026 and is not on file with the SEC yet.
What Longeveron Inc. does
Longeveron Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker LGVN.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $1.2M | -$22.7M | -$1.29 | -$18.9M |
| 2024 | $2.4M | -$16M | -$2.62 | -$14.5M |
| 2023 | $709K | -$21.4M | -$10.22 | -$19.3M |
| 2022 | $1.2M | -$18.8M | -$9.02 | -$14.5M |
| 2021 | $1.3M | -$17M | -$9.02 | -$10M |
| 2021 | $5.6M | -$3.7M | -$2.30 | -$2.5M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where LGVN ranks in Health care
Latest SEC filings
What Longeveron Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 23, 2026Other event 8-K
- September 14, 2026Other event 8-K
- September 10, 2026Passive stake (5% or more) SCHEDULE 13G
- August 24, 2026
- August 19, 2026
- August 13, 2026Passive stake changed SCHEDULE 13G/A
- August 12, 2026
- August 12, 2026Quarterly report 10-Q · period to June 30, 2026Revenue fell 9.2% to $287K versus the same quarter last year; diluted EPS -$0.19 versus -$0.33.
- August 10, 2026Passive stake (5% or more) SCHEDULE 13G
- July 29, 2026Other event 8-K
Insider trades
What the people running Longeveron Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 17 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| October 1, 2026 | Blass DevinCTO & SVP of CMC | Shares withheld for tax | 2,520 | $6.5K |
| October 1, 2026 | Lehr Paul TGeneral Counsel, Secretary | Shares withheld for tax | 2,253 | $5.8K |
| October 1, 2026 | Agafonova NataliyaChief Medical Officer | Shares withheld for tax | 2,913 | $7.5K |
| October 1, 2026 | Willard Stephen HChief Executive Officer | Shares withheld for tax | 1,987 | $5.1K |
| October 1, 2026 | Jhaveri Nirav S.Chief Financial Officer | Shares withheld for tax | 742 | $1.9K |
| August 19, 2026 | Hare JoshuaChief Scientific Officer, Director, 10% owner | Received as pay | 286,000 | - |
| August 19, 2026 | Agafonova NataliyaChief Medical Officer | Received as pay | 286,000 | - |
| August 19, 2026 | Blass DevinCTO & SVP of CMC | Received as pay | 286,000 | - |
Who owns LGVN
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Joshua M. Hare, M.D.13D, may seek influence | 25.7% | April 15, 2024 |
| Mitchell P. Kopin13G, passive with 2 related filers | 9% | August 13, 2026 |
| Logos Global Management LP13G, passive with 5 related filers | 6.3% | September 10, 2026 |
| Janus Henderson Group PLC13G, passive | 5.9% | May 15, 2026 |
| Integrated Core Strategies (US) LLC13G, passive with 3 related filers | 5.2% | August 10, 2026 |
Largest institutional holders
Insiders
15 insiders reported holding 4,409,894 shares in total, about $14M at the last price.
| Holder | Shares |
|---|---|
| Hare JoshuaChief Scientific Officer, Director, 10% owner | 2,929,592 |
| Locklear LisaChief Financial Officer | 443,181 |
| Soffer RockDirector | 262,034 |
| Powell James NathanielChief Executive Officer | 125,593 |
| Lehr Paul TGeneral Counsel, Secretary | 83,889 |
| Ungaro UrsulaDirector | 77,000 |
| Willard Stephen HChief Executive Officer | 74,916 |
| Paletta George A. Jr.Director | 70,000 |
| Hajjar Roger JosephDirector | 69,000 |
| Agafonova NataliyaChief Medical Officer | 68,778 |
Questions about LGVN
What does Longeveron Inc. do?
Longeveron Inc. is a company in the Health care sector, listed on NASDAQ as LGVN. Its shares trade on NASDAQ under the ticker LGVN.
What is Longeveron Inc.'s net worth?
Longeveron Inc. has a market value (market cap) of $101.4M at the latest share price, and shareholders' equity of $10.4M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Longeveron Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $23.5M on revenue of $1.2M.
How much revenue does Longeveron Inc. make?
Over the twelve months to June 30, 2026 Longeveron Inc. reported revenue of $1.2M. That is 42.7% less than a year earlier.
When did Longeveron Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 12, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from October 5, 2026.
When is Longeveron Inc.'s next earnings report?
Longeveron Inc.'s next report was expected around November 3, 2026 and is not on file with the SEC yet.
Similar companies
Compare LGVN with
Follow LGVN
Get an email when Longeveron Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Longeveron Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.